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Counterfeit of medicines is highly problematic throughout developing countries. First it poses 
a direct threat to the lives of patients. Second, it contributes to the development of drug-resistant 
strains, dramatic for killing diseases such as malaria, infections, and to lack of symptoms relieve such 
as pain and fever, etc. A picture of results published from large scale studies  illustrates the situation 
in some African countries where it has even been estimated up to 80% of medical products 
counterfeit [1, 2]. 
Non-steroidal anti-inflammatory drugs (NSAIDs) are used against pain, fevers of various 
origins and inflammation. They are widely prescribed throughout the world. Many of them are 
associated with side effects. These drugs are often used in self-medication, as their purchase is often 
unrestricted over the Internet. The risk of administration of uncontrolled medicines is thus naturally 
greater. However, health authorities at national, regional and international levels are still trying to 
fight against this scourge by the application of several strategies that needs to be reinforced through 
adequate analytical methods for quality control. It is important to note that, to help their use, these 
analytical methods must be generic, fast and have specific detection. In this context, a strategy 
focused on three axes is presented: At first, generic analytical methods were developed by means of 
experimental design combined with a novel Design Space optimisation strategy [3]. It aimed at 
detecting and tracing simultaneously 18 NSAIDs drugs, 5 pharmaceutical conservatives, paracetamol, 
chlorzoxazone, caffeine and salicylic acid. Liquid Chromatography combined with UV detection was 
considered. In order to provide faster analysis and reduce solvent consumption, a transfer to Ultra 
High Performance Liquid Chromatography also combined with UV detection was the second part of 
the planned study. Finally, the quantitative methods were applied to analyze several drugs marketed 
in the Democratic Republic of Congo. On the basis of the dramatic results obtained, it was confirmed 
that substandard and counterfeit medicines remain a crucial problem on public health in low-income 
countries. 
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